Join        Login             Stock Quote

Sanofi (SNY) Plans To Raise Stake In Regeneron (REGN), Shares Up

 February 11, 2013 02:38 PM

(By Balachander) Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) said its partner Sanofi SA (NYSE: SNY) plans to raise its stake in the drug maker by acquiring shares in open market.

REGN stock, which has risen 24 percent in the last 3 months, gained 2.79 percent to trade at $170.50 on Monday. SNY shares jumped 3.42 percent to trade at $48.11.

France-based Sanofi, which currently owns roughly 16 million shares or 17 percent of Regeneron, plans to own in excess of $500 million in voting securities.

[Related -Regeneron Pharmaceuticals Inc (REGN): Well Positioned To Rival Amgen In Multi-Billion Dollar Cholesterol Drug Market]

Under a December 2007 investor agreement, Sanofi is bound by certain "standstill" provisions including an agreement not to acquire more than 30 percent of Regeneron's class A stock and common stock. 

These standstill provisions are effective until the fifth anniversary of the expiration or earlier termination of a license and collaboration agreement between the companies, the Tarrytown, New York-based Regeneron said.

Sanofi and Regeneron have both developed cancer drug Zaltrap, which has been approved by the U.S. Food and Drug Administration (FDA) and European regulators as a treatment for colorectal cancer. The companies have also agreed to colloborate on other drugs.

REGN shares have been trading in the 52-week range of $94.22 to $188.95.

iOnTheMarket Premium


Post Comment -- Login is required to post message
Alert for new comments:
Your email:
Your Website:

rss feed

Latest Stories

article imageEmerging-Markets Stocks Took The Lead Last Week

Emerging-markets equities enjoyed a solid rise last week among the major asset classes, based on a set of read on...

article imageDoes Your Latest Investment Pass This Test?

On Wednesday, I sounded the alarm about the problems looming for some consumer staples stocks. In short, read on...

article imageIs The Slump In US Manufacturing Easing?

Yesterday’s November survey data from the Philadelphia Fed hints at the possibility that a stronger trend read on...

article imageMarket Potentially Facing Near Term Technical Headwinds

After the S&P 500 Index pullback on Thursday and Friday last week, the market's advance on Monday and read on...

Popular Articles

Daily Sector Scan
Partner Center

Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.